top of page
Schizophrenia and Covid-19
Presented By:
Dr. Nicole Kozloff and Dr. Aristotle Voineskos
Learning Objectives:
-
Discuss the increased risk of infection and poor outcomes among people with schizophrenia.
-
Review anticipated adverse mental health consequences for people with schizophrenia.
-
Discuss adaptations to mental health service delivery in inpatient and outpatient settings.
-
Consider potential impact on clinical research in schizophrenia.
Originally Presented at the 2021 Fall Expert Speaker Series
This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance through an educational grant.
bottom of page